Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study by Venkatesan, Sudhir et al.
Development of processes allowing near
real-time refinement and validation of
triage tools during the early stage
of an outbreak in readiness for surge:
the FLU-CATs Study
Sudhir Venkatesan,1† Puja R Myles,1† Gerard McCann,2
Antonis A Kousoulis,2 Maimoona Hashmi,2
Rabah Belatri,2 Emma Boyle,2 Alan Barcroft,2
Tjeerd Pieter van Staa,3 Jamie J Kirkham,4
Jonathan S Nguyen Van Tam,1 Timothy J Williams2
and Malcolm G Semple4*
1Division of Epidemiology and Public Health, University of Nottingham,
Nottingham, UK
2Clinical Practice Research Datalink, Medicines and Healthcare products
Regulatory Agency, London, UK
3University of Manchester, Manchester, UK
4Institute of Translational Medicine, University of Liverpool, Liverpool, UK
*Corresponding author
†Joint first authors
Declared competing interests of authors: SV, PRM, GMcC, AAK, MH, RB, EB, AB, TPvS, JJK, JSNVT,
JSW and MGS were in receipt of grants from the National Institute for Health Research (NIHR), both for the
conduct of this study and others. In addition, PRM reports grants from F. Hoffman La Roche outside
the submitted work, and TPvS has participated in expert meetings with GlaxoSmithKline and Boehringer
(not related to flu) and has provided methodological advice to Laser (including an observational study on
the incidence of flu). The Clinical Practice Research Datalink is a joint venture between the UK Medicines
and Healthcare products Regulatory Agency and NIHR.
Published October 2015
DOI: 10.3310/hta19890
Scientific summary
The FLU-CATs Study
Health Technology Assessment 2015; Vol. 19: No. 89
DOI: 10.3310/hta19890
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Scientific summary
Background
During pandemics of novel influenza and outbreaks of other emerging infections, surge in health-care
demand can exceed capacity to provide normal standards of care. During surge, workload pressures may
limit the time available for clinical decision-making and health-care worker absence because of personal
sickness, or caring for dependants, may limit the skill mix. Imaging and laboratory services may also be
limited. Health-care workers who are unfamiliar with clinical assessment and admission decision-making
may be asked to fulfil ‘gatekeeper’ roles. In such exceptional circumstances, triage tools may aid decisions
in identifying people who are most likely to benefit from higher levels of care.
Provisional UK Emergency Planning Guidance published in 2007 suggested the use of the CURB-65
pneumonia score and the Pandemic Medical Early Warning Score (PMEWS) for hospital triage of adults,
but did not address the needs of children. Recognising this gap, a ‘toolkit’ of national guidance was
developed in 2008 by the Department of Health for the UK, which included the newly developed
Community Assessment Tools (CATs) for both children and adults in primary and secondary care, and
matched hospital care pathways. The validity and utility of using triage tools in the community to aid
management decisions during a pandemic remains untested. Both PMEWS and CATs were developed
specifically with this purpose in mind and so we aimed to capture the criteria that would allow validation
of these tools in this study.
The validity and utility of triage tools needs to be assessed in a large community-based prospective study of
patients presenting with influenza-like illness (ILI), to give confidence to general practitioners (GPs) who
may be asked to use such tools in the event of surge, and policy-makers who may need to recommend
their use to GPs. Validation of a triage tool for use in an outbreak of a novel disease requires rapid
research during the early phase of that outbreak. Rapid research should allow refinement and validation
of triage tools so that in the event of surge a valid tool is available.
Objectives
1. In preparation for conducting rapid research in the early phase of a future outbreak To develop
information technology (IT) infrastructure and processes that allow near real-time analysis of GP
assessments of people presenting with ILI, and GP management decisions and patient outcomes.
2. As proof of concept and to test processes To conduct a pilot study evaluating the performance of the
triage tools ‘CATs’ and ‘PMEWS’ in predicting hospital admission and death in patients presenting with
ILIs to GPs during inter-pandemic winter seasons.
3. To conduct a prospective near real-time analysis of structured clinical assessments for ILI using primary
care electronic health records (EHRs) during a pandemic.
This report addresses only the first two objectives, involving preparatory work that would make the third
objective feasible in the event of a pandemic.
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Methods
Aim
The overarching study aim is to conduct a prospective near real-time analysis of structured clinical
assessments of ILI using primary care EHRs during a pandemic. This report covers the preparatory work,
that is, IT infrastructure development, user testing and pilot study as ‘proof of concept’.
Design
The proof-of-concept study involved setting up and piloting a prospective near real-time analysis of
structured clinical assessments and anonymised linkage to data from EHRs. User (GP) experience was
evaluated by semistructured interviews. Processes were also developed for retrospective validation
of outcome events using Hospital Episode Statistics (HES) and Office for National Statistics (ONS)
mortality data.
Setting
Thirty GPs in England, Wales and Scotland participating in the Clinical Practice Research Datalink (CPRD)
using the Vision® version 3.01 (In Practice Systems Ltd, London, UK) EHR.
Participants
All people presenting with ILIs to participating GPs.
Interventions
None.
Main outcome measures
Study outcome is proof of concept through demonstration of data capture, appropriateness of data
definitions and near real-time analysis. Primary patient outcomes are hospital admission within 24 hours
and death (all causes) within 30 days of GP assessment. Secondary patient outcomes included GP decision
to prescribe antibiotics and/or influenza-specific antivirals and/or refer to hospital, need for higher levels
of care if admitted, and length of hospital stay.
Data sources
Linked anonymised data from a study-specific web-based structured clinical assessment and primary care
patient EHRs. Retrospective validation of hospital admission was planned using HES, and mortality data
validation was planned using ONS data.
Results
In the 24 months prior to April 2015, data from 704 adult and 159 child consultations to 30 GPs were
captured. Influenza activity during these two winter seasons was low. GPs decided to refer 11 (1.6%)
adults and 6 (3.8%) children to hospital. There were 13 (1.8%) deaths among adults and 2 (1.3%)
among children. There were too few outcome events from which to draw any conclusions regarding the
performance of the triage tools; however, the data captured allowed testing of almost all analytical
algorithms and demonstrated proof of concept.
Data relating to each GP consultation were uploaded on to the CPRD database every night. The CPRD
team then collated these data and sent weekly data to researchers based at the Universities of Nottingham
and Liverpool. Additionally, on a monthly basis, the CPRD team sent background data (comorbidities,
prescriptions, death, etc.) sourced from the EHRs for all patients with captured consultations. Each
subsequent data instalment comprised the cumulative data acquired since the initiation of the study.
Validation of outcome events with HES and ONS data was not possible for inclusion in this interim report
because of a moratorium on provision of this data by the Health and Social Care Information Centre.
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Six participating GPs agreed to be interviewed about their user experience. The main finding that emerged
from these interviews was that the Local Eligibility Patient Identification Software (LEPIS) and web-based
electronic Case Report Forms (eCRFs) were easy to use. The simplicity of the eCRFs encouraged GPs to
participate in the study despite there not being any financial incentive for participation.
The GPs reported that the triage process of the consultation was quite easy to conduct and did not
interfere with the routine GP consultation. Several GPs felt that a monetary incentive, even if small, would
be necessary to increase GP participation in the study unless there was a statutory requirement to
systematically collect data on all possible influenza cases during a pandemic. All interviewed GPs agreed
that the FLU-CATs eCRF, with a few modifications, was ready to be used in a pandemic scenario.
However, the setting up of the LEPIS system to enable data collection for the study was fraught with
technical difficulties and not compatible with other EHR systems in use in the UK. Both these points are
important limitations that would prevent a rapid national level rollout beyond the 650 plus practices
currently using the Vision® EHR platform. Any decision aid based on the validated criteria could better be
delivered separately on an open web-based platform or mobile phone ‘app’.
Lessons learnt from the data analysis included that up to 74% of some clinical measurements (blood
pressure in adults in this instance) were not recorded as part of GP’s routine assessment of an adult person
presenting with ILI. We would question the utility and adoption of triage tools that depend upon a clinical
measurement that is not used in the routine assessment of ILI for use in a time-pressured pandemic situation.
Conclusions
The use of EHRs linked to study-specific data capture forms increased the comprehensiveness, validity and
usability of data; pre-prepared analytical processes allowed near real-time analysis of GP assessments,
management decisions and patient outcomes on a weekly basis. The processes are dynamic and should
allow refinement of triage criteria in the early stages of a future outbreak.
Future work
We will test the effect of minimal remuneration on recruitment in future seasons, develop processes to
include other EHR systems, attempt linkage to data on influenza surveillance and maintain processes in
readiness for a future outbreak.
Study registration
This study is registered as ISRCTN87130712 and UK Clinical Research Network 12827.
Funding
The National Institute for Health Research Health Technology Assessment programme. MGS is supported
by the UK NIHR Health Protection Research Unit in Emerging and Zoonotic Infections.
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